Suppr超能文献

胃弥漫型胃癌诊断评分模型的建立与内部验证。

Development and internal validation of a diagnostic score for gastric linitis plastica.

机构信息

Service de Gastroentérologie, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France.

Service de Biostatistique, Hôpital Saint-Louis, Paris, France.

出版信息

Gastric Cancer. 2020 Jul;23(4):639-647. doi: 10.1007/s10120-020-01051-x. Epub 2020 Feb 26.

Abstract

BACKGROUND

There is no consensual definition for gastric linitis plastica (GLP). We aim to construct a diagnostic score to distinguish this rare tumor from usual gastric adenocarcinomas.

METHODS

In this retrospective study, all patients who had gastrectomy for cancer between 2007 and 2017 in French tertiary centers were included. The outcome was a diagnosis of GLP based on pathological review of the surgical specimen. The diagnostic score was created by using variables that were most frequently associated with GLP using penalized logistic regression on multiply imputed datasets. We used discrimination measures to assess the performances of the score. Internal validation was performed using bootstrapping methods to correct for over-optimism.

RESULTS

220 patients including 71 linitis plastica (female 49%, median age 57 years) were analyzed. The six parameters retained in the diagnosis score were the presence of large folds and/or parietal thickening on at least one segment, pangastric infiltration and presence of gastric stenosis on the upper endoscopy, circumferential thickening on at least one segment and thickening of the third hyperechogenic layer on endoscopic ultrasound and the presence of signet ring cells on endoscopic biopsies. The area under the ROC curve (AUC) was 0.967 with a sensitivity of 94% [89.9-97.3] and a specificity of 88.7% [81.7-95.8] for a threshold of 2.75. After internal validation, the corrected AUC was 0.959.

CONCLUSION

It is the first study validating a pre-therapeutic diagnostic score (Saint Louis linitis score) with an excellent ability to discriminate GLP from non-GLP adenocarcinomas. An external validation is necessary to confirm our data.

摘要

背景

胃弥漫型大B 细胞淋巴瘤(GLP)目前尚无统一的定义。本研究旨在构建一种诊断评分系统,以区分这种罕见肿瘤与常见的胃腺癌。

方法

本回顾性研究纳入了 2007 年至 2017 年期间在法国三级中心接受胃切除术治疗癌症的所有患者。基于手术标本的病理复查结果来诊断 GLP。使用惩罚逻辑回归对多重插补数据集进行分析,确定与 GLP 最相关的变量,从而构建诊断评分。使用判别指标评估评分的性能。采用 bootstrap 方法对内部分类进行验证,以纠正过度拟合。

结果

共纳入 220 例患者,其中 71 例为弥漫型大 B 细胞淋巴瘤(女性占 49%,中位年龄为 57 岁)。诊断评分中保留的 6 个参数为:至少一个节段存在大皱襞和/或壁层增厚、全胃浸润、上消化道内镜检查可见胃狭窄、至少一个节段存在环形增厚、内镜超声可见第三高回声层增厚、内镜活检可见印戒细胞。ROC 曲线下面积(AUC)为 0.967,其敏感性为 94%(89.9%-97.3%),特异性为 88.7%(81.7%-95.8%),截断值为 2.75。内部验证后,校正 AUC 为 0.959。

结论

这是第一项验证术前诊断评分(圣路易斯弥漫型大 B 细胞淋巴瘤评分)的研究,该评分具有极好的鉴别 GLP 与非 GLP 腺癌的能力。需要进一步的外部验证来确认我们的数据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验